Chinese Medicine Yishen Jiangu Granules (益肾健骨颗粒) on Aromatase Inhibitor-Associated Musculoskeletal Symptoms
- 38 Downloads
To assess the effectiveness of Yishen Jiangu Granules (益肾健骨颗粒, YSJGG) on aromatase inhibitor-associated musculoskeletal symptoms (AIMSS).
A single-arm, open-label study was conducted in 34 postmenopausal women with breast cancer who experienced AIMSS. Patients were treated with YSJGG for 12 weeks (12.4 g orally twice daily). The primary outcome was a change in the mean worst pain score of Brief Pain Inventory-Short Form (BPI-SF) over 12 weeks, and the second outcomes included changes in pain severity and pain-related interference of BPI-SF and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Modified Score for the Assessment of Chronic Rheumatoid Affections of the Hands (M-SACRAH), the Functional Assessment of Cancer Therapy-Breast (FACT-B), bone mineral density (BMD) and blood indices such as calcium (Ca), phosphate (P), and alkaline phosphatase (ALP).
Of 37 women recruited, 30 initiated the therapy and 24 were evaluable at 12 weeks. The primary outcome (BPI-SF worst pain scores) achieved a 2.17-point reduction compared with baseline (5.75±1.87 vs 3.58±2.15, P<0.01). There were reductions in pain severity (decreased 1.65, P<0.01) and pain-related interference (decreased 2.55, P<0.01). The changes in WOMAC and M-SACRAH scores were similar to BPI-SF (P<0.05). In the FACT-B, only physical well-being and functional well-being were improved compared with baseline (P<0.05). No clinical differences were found in BMD, Ca, P and ALP.
YSJGG is an effective and well-tolerated agent to reduce AIMSS.
Keywordsaromatase inhibitors breast cancer musculoskeletal symptoms Chinese medicine Yishen Jiangu Granules
Unable to display preview. Download preview PDF.
- 6.Zhou D, ed. Oncology of traditional Chinese medicine. Beijing: China Press of Traditional Chinese Medicine; 2011:16–39.Google Scholar
- 7.Sun G, Tong Y, Chen W, eds. Basic theory of traditional Chinese medicine. Beijng: China Press of Traditional Chinese Medicine; 2002:72–98.Google Scholar
- 8.Peng N, Zhang Y, Ma C, Yu M, Yang G, Fu Q. Effects of the traditional Chinese medicine Yi Shen Jian Gu Granules on aromatase inhibitor-associated musculoskeletal symptoms: a study protocol for a multicenter, randomized, controlled clinical trial. Trials 2014;15:171.CrossRefPubMedPubMedCentralGoogle Scholar
- 9.Coleman R, Body JJ, Aapro M, Hadji P, Herrstedt J. Bone health in cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol 2014;25 Suppl 3:iii124–137.Google Scholar
- 11.Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988;15:1833–1840.PubMedGoogle Scholar
- 16.Zhong L, Zhang W, Hua Y, Ji P, Yao W, Li J. et al. Metabolomic evaluation for anti-inflammatory effect of volatile oils from different preparations of Angelicae Sinensis Radix. China J Chin Mater Med (Chin) 2016;41:2061–2069.Google Scholar
- 17.Yang Q, Yang L, Xiong A, Lu L, Wang R, Wang Z. Metabolomics study of anti-inflammatory action of Radix Paeoniae Rubra and Radix Paeoniae Alba by ultraperformance liquid chromatography–mass spectrometry. China J Chin Mater Med (Chin) 2011;36:694–697.Google Scholar
- 18.Huang J, Fang M, Li Y, Ma Y, Cai X. Analgesic effect of Corydalis yanhusuo in a rat model of trigeminal neuropathic pain. J Nanfang Med Univ (Chin) 2010;30:2161–2164.Google Scholar